PhD in neuroscience, I specialized in pre-clinical pharmacology especially in neurodegenerative diseases. During my professional experiences, I acquired a strong expertise on new therapies to counteract the natural course of various diseases such as Alzheimer's disease, stroke as well as Down syndrome.
To do so, I had to adapt the treatment used (by recombinant proteins, synthetic pharmacological products or by gene transfer) based on the specifications imposed by the characteristics of each pathologies.
Specialties: Pharmacology, Transfer of therapeutic genes, Pathophysiology, Rodent behavior, Data management, Alzheimer, Stroke, Down syndrome.
Postdoctoral Researcher CEA fontenay-Aux-Roses
Since April 2011
"Development of rodent models of neurodegenerative disease by gene transfer"
"Pre-Clinical Development of treatments for cognitive deficits in Alzheimer's disease mouse models"
PhD student Hôpital Henri-Mondor Créteil, France
Since October 2003
"Stroke pathophysiology, modeling and neuroprotective studies."
Postdoctoral Researcher Paris, France
October 2009 --- March 2011
"Preclinical development of a GABA-A receptor α5 subtype inverse agonist in a mouse model of Down syndrome: analysis of genetic effects following chronic injection"
Postdoctoral Researcher Orsay, France
April 2008 --- September 2009
"Preclinical development of a GABA-A receptor α5 subtype inverse agonist in a mouse model of Down syndrome: analysis of memory effects following acute injection"
Researcher Parc Biocitech, 93210 Romainville
February 2007 --- January 2008
"Establishment of left coronary artery occlusion rat model, efficacy study of cardioprotective compounds"
Animal models R&DActions and modes of action of human physiologyAnimal trialBiostatisticsBudget ManagementData ManagementIn VivoNeurosciencePre-clinical researchSurgery
PhD in Neuroscience from Université Paris-Est Créteil (UPEC) in 2006
in from Université Paris-Est Créteil (UPEC) in 2003
in from Université Paris Sud (Paris XI) in 0
in from in 0